| - |
Azelastine hydrochloride and fluticasone propionate (nasal spray) |
Dymista® |
For symptomatic treatment of moderate-to-severe allergic rhinitis, in patients aged 12 years and older for whom monotherapy with either intranasal antihistamine or glucocorticoid is not considered sufficient. |
Rapid Review Complete |
28th February 2013 |
 |
| - |
Fidaxomicin |
Dificlir® |
For the treatment of CDI also known as CDAD in adult patients. Rapid Review |
Assessment process complete |
5th February 2013 |
|
| - |
Ivacaftor |
Kalydeco® |
For the treatment of cystic fibrosis in patients age 6 years and older who have the G551D mutation |
Assessment process complete |
1st February 2013 |
|
| - |
Lisdexamfetamine dimesylate |
Tyvense® |
For Attention Deficit Hyperactivity Disorder in children aged 6 years and over when response to previous methylphenidate treatment is considered clinically inadequate. |
Rapid Review Complete |
28th February 2013 |
|
| __ |
__ |
__ |
__ |
__ |
28th February 2013 |
|
